The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix
Open accessAbstract
Biofilm-associated polymicrobial infections, particularly those involving fungi and bacteria, are responsible for significant morbidity and mortality and tend to be challenging to treat. Candida albicans and Staphylococcus aureus specifically are considered leading opportunistic fungal and bacterial pathogens, respectively, mainly due to their ability to form biofilms on catheters and indwelling medical devices. However, the impact of mixed-species biofilm growth on therapy remains largely understudied. In this study, we investigated the influence of C. albicans secreted cell wall polysaccharides on the response of S. aureus to antibacterial agents in biofilm. Results demonstrated significantly enhanced tolerance for S. aureus to drugs in the presence of C. albicans or its secreted cell wall polysaccharide material. Fluorescence confocal time-lapse microscopy revealed impairment of drug diffusion through the mixed biofilm matrix. Using C. albicans mutant strains with modulated cell wall polysaccharide expression, exogenous supplementation, and enzymatic degradation, the C. albicans -secreted β-1,3-glucan cell wall component was identified as the key matrix constituent providing the bacteria with enhanced drug tolerance. Further, antibody labeling demonstrated rapid coating of the bacteria by the C. albicans matrix material. Importantly, via its effect on the fungal biofilm matrix, the antifungal caspofungin sensitized the bacteria to the drugs. Understanding such symbiotic interactions with clinical relevance between microbial species in biofilms will greatly aid in overcoming the limitations of current therapies and in defining potential new targets for treating polymicrobial infections. IMPORTANCE The fungus Candida albicans and the bacterium Staphylococcus aureus are important microbial pathogens responsible for the majority of infections in hospitalized patients and are often coisolated from a host. In this study, we demonstrated that when grown together, the fungus provides the bacterium with enhanced tolerance to antimicrobial drugs. This process was mediated by polysaccharides secreted by the fungal cell into the environment. The biofilm matrix formed by these polysaccharides prevented penetration by the drugs and provided the bacteria with protection. Importantly, we show that by inhibiting the production of the fungal polysaccharides, a specific antifungal agent indirectly sensitized the bacteria to antimicrobials. Understanding the therapeutic implications of the interactions between these two diverse microbial species will aid in overcoming the limitations of current therapies and in defining new targets for treating complex polymicrobial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“The growing use of implanted medical devices is another reason why the incidence of Candida and staphylococcal infections has steadily increased, since the majority of these infections are emerging from biofilms formed on medical implants (10, 13, 23, 30, 31).”
BackgroundBiofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Gillum, A. M., Tsay, E. Y. H., & Kirsch, D. R. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328721 · Cited by 1,251
Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
Calderone, R. (2012) · ASM Press eBooks · Cited by 912
Polymicrobial Interactions: Impact on Pathogenesis and Human Disease
Peters, B. M., Jabra-Rizk, M. A., O'May, G. A., Costerton, J. W., & Shirtliff, M. E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-11 · Cited by 712
Self-citationGenetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612
Otto, M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-140023 · Cited by 606
Harriott, M. M., & Noverr, M. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00657-09 · Cited by 529
Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology
Tenover, F. C., & Goering, R. V. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp241 · Cited by 441
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Self-citationPutative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407
Self-citationCross-kingdom interactions:Candida albicans and bacteria
Shirtliff, M. E., Peters, B. M., & Jabra-Rizk, M. A. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01668.x · Cited by 400
Self-citationMixed species biofilms of Candida albicans and Staphylococcus epidermidis
ADAM, B., BAILLIE, G. S., & DOUGLAS, L. J. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-4-344 · Cited by 374
Human polymicrobial infections
BROGDEN, K., Guthmiller, J. M., & TAYLOR, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17745-9 · Cited by 370
Effect of Farnesol on Staphylococcus aureus Biofilm Formation and Antimicrobial Susceptibility
Jabra-Rizk, M. A., Meiller, T. F., James, C. E., & Shirtliff, M. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1463-1469.2006 · Cited by 341
Self-citationBiofilm Matrix Regulation by Candida albicans Zap1
Nobile, C. J., Nett, J. E., Hernday, A. D., Homann, O. R., Deneault, J.-S., Nantel, A., Andes, D. R., Johnson, A. D., & Mitchell, A. P. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000133 · Cited by 337
Self-citationNovel Entries in a Fungal Biofilm Matrix Encyclopedia
Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., et al. (2014) · mBio · doi:10.1128/mbio.01333-14 · Cited by 315
Self-citationImportance of Candida–bacterial polymicrobial biofilms in disease
Harriott, M. M., & Noverr, M. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.07.004 · Cited by 313
Candida albicans forms biofilms on the vaginal mucosa
Harriott, M. M., Lilly, E. A., Rodriguez, T. E., Fidel, P. L., & Noverr, M. C. (2010) · Microbiology · doi:10.1099/mic.0.039354-0 · Cited by 301 · cited 1×
“albicans and staphylococcus mixed biofilms has been reported, the mechanism and specific factors behind these observations remain undefined (40, 41).”
BackgroundA Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291
Self-citationPeters, B. M., Jabra-Rizk, M. A., Scheper, M. A., Leid, J. G., Costerton, J. W., & Shirtliff, M. E. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00710.x · Cited by 287
Self-citationIncreasing Antibiotic Resistance among Methicillin‐Resistant Staphylococcus aureus Strains
Sakoulas, G., & Moellering, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/533592 · Cited by 274
Candida albicans Interactions with Bacteria in the Context of Human Health and Disease
Morales, D. K., & Hogan, D. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000886 · Cited by 270
Jin, Y., Yip, H. K., Samaranayake, Y. H., Yau, J. Y., & Samaranayake, L. P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.7.2961-2967.2003 · Cited by 254
Klotz, S. A., Chasin, B. S., Powell, B., Gaur, N. K., & Lipke, P. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.07.001 · Cited by 253
Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p
Peters, B. M., Ovchinnikova, E. S., Krom, B. P., Schlecht, L. M., Zhou, H., Hoyer, L. L., Busscher, H. J., van der Mei, H. C., Jabra-Rizk, M. A., & Shirtliff, M. E. (2012) · Microbiology · doi:10.1099/mic.0.062109-0 · Cited by 250
Self-citationBaena-Monroy, T., Moreno-Maldonado, V., Franco-Martínez, F., Aldape-Barrios, B., Quindós, G., & Sánchez-Vargas, L. O. (2005) · PubMed · Cited by 233
Candida albicans biofilm development, modeling a host–pathogen interaction
Nett, J., & Andes, D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.007 · Cited by 210
Self-citationMannosylation in Candida albicans: role in cell wall function and immune recognition
Hall, R. A., & Gow, N. A. R. (2013) · Molecular Microbiology · doi:10.1111/mmi.12426 · Cited by 210
Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207
Self-citationMucosal biofilms of Candida albicans
Ganguly, S., & Mitchell, A. P. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.001 · Cited by 200
Munro, C. A., Bates, S., Buurman, E. T., Hughes, H. B., MacCallum, D. M., Bertram, G., Atrih, A., Ferguson, M. A. J., Bain, J. M., Brand, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411413200 · Cited by 200
Community participation in biofilm matrix assembly and function
Mitchell, K. F., Zarnowski, R., Sanchez, H., Edward, J. A., Reinicke, E. L., Nett, J. E., Mitchell, A. P., & Andes, D. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421437112 · Cited by 183
Self-citationLoss of Cell Wall Mannosylphosphate in Candida albicans Does Not Influence Macrophage Recognition
Hobson, R. P., Munro, C. A., Bates, S., MacCallum, D. M., Cutler, J. E., Heinsbroek, S. E. M., Brown, G. D., Odds, F. C., & Gow, N. A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405003200 · Cited by 133
Chauvel, M., Nesseir, A., Cabral, V., Znaidi, S., Goyard, S., Bachellier‐Bassi, S., Firon, A., Legrand, M., Diogo, D., Naulleau, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045912 · Cited by 124
CandidaBiofilms and the Host: Models and New Concepts for Eradication
Tournu, H., & Dijck, P. V. (2011) · International Journal of Microbiology · doi:10.1155/2012/845352 · Cited by 115
Pereira, P. M., Filipe, S. R., Tomasz, A., & Pinho, M. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00431-07 · Cited by 113
Brucker, K. D., Tan, Y., Vints, K., Cremer, K. D., Braem, A., Verstraeten, N., Michiels, J. J., Vleugels, J., Cammue, B. P. A., & Thevissen, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04650-14 · Cited by 107
Lazzell, A. L., Chaturvedi, A. K., Pierce, C. G., Prasad, D., Uppuluri, P., & Lopez-Ribot, J. L. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp242 · Cited by 105
Clinical Implications of Oral Candidiasis: Host Tissue Damage and Disseminated Bacterial Disease
Kong, E. F., Kucharíková, S., Dijck, P. V., Peters, B. M., Shirtliff, M. E., & Jabra‐Rizk, M. A. (2014) · Infection and Immunity · doi:10.1128/iai.02843-14 · Cited by 85
Self-citationInteractions between bacteria and Candida in the burn wound
Gupta, N., Haque, A., Mukhopadhyay, G., Narayan, R. P., & Prasad, R. (2005) · Burns · doi:10.1016/j.burns.2004.11.012 · Cited by 81
Mixed bloodstream infections involving bacteria and Candida spp.
Bouza, E., Burillo, A., Muñóz, P., Guinea, J., Marín, M., & Rodríguez‐Créixems, M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt099 · Cited by 76
Prevalence and spectrum of bacterial co-infection during fungal keratitis
Pate, J. C., Jones, D. B., & Wilhelmus, K. R. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081869 · Cited by 72
Methicillin-resistant Staphylococcus aureus and Candida albicans on denture surfaces.
Tawara, Y., Honma, K., & Naito, Y. (1996) · PubMed · Cited by 70
Chrissoheris, M. P., Libertin, C. R., Ali, R., Ghantous, A. E., Bekui, A. M., & Donohue, T. J. (2009) · Clinical Cardiology · doi:10.1002/clc.20498 · Cited by 68
Ghannoum, M. A., Roilides, E., Katragkou, A., Petraitis, V., & Walsh, T. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ815 · Cited by 62
Southard, S. B., Specht, C. A., Mishra, C., Chen-Weiner, J., & Robbins, P. W. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.24.7439-7448.1999 · Cited by 57
Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients
Sancho, S., Artero, A., Zaragoza, R., Camarena, J. J., González, R., & Nogueira, J. M. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1503-8 · Cited by 50
Pathogenesis of Polymicrobial Biofilms
Jabra‐Rizk, M. A. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010039 · Cited by 30
Self-citationThe Staphylococci and Staphylococcal Pathogenesis
Mcgavin, M. J., & Heinrichs, D. E. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00066 · Cited by 17
Cited by
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Biofilm Matrixome: Extracellular Components in Structured Microbial Communities
Karygianni, L., Ren, Z., Koo, H., & Thurnheer, T. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.016 · Cited by 1,487
The wound microbiota: microbial mechanisms of impaired wound healing and infection
Uberoi, A., McCready-Vangi, A., & Grice, E. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01035-z · Cited by 864
Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
Schilcher, K., & Horswill, A. R. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-19 · Cited by 706
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Metadata
- Authors
- Kong, E. F., Tsui, C., Kucharíková, S., Andes, D., Van Dijck, P., & Jabra-Rizk, M. A.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2016-11-02
- Volume
- 7
- Issue
- 5
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2530495088
- Cited by
- 294
- References
- 52
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.